Led by Professor Toshiaki Akita of Nagoya University, iCorNet has developed a support network to slow down the progression of DCM and alleviate the burdens it places on patients. DCM is a chronic and difficult-to-treat disease, with limited options such as medication and heart transplant. Recognizing the need for alternative treatments, iCorNet focuses on the research and development of a support network that aims to improve patients' quality of life and extend their lifespan.

With promising results from clinical studies, iCorNet is now conducting trials towards gaining approval. By participating in these trials, you can play a crucial role in helping the estimated 20,000 DCM patients throughout Japan. Choose hope and support a brighter future with iCorNet's groundbreaking research